We are live on
!
Find out more
AAM
Azzad Asset Management Portfolio holdings
AUM
$989M
1-Year Est. Return
27.02%
This Fund
S&P 500
This Quarter
Est. Return
+7.91%
1 Year Est. Return
+27.02%
3 Year Est. Return
+77.73%
5 Year Est. Return
+108.06%
10 Year Est. Return
+478.13%
AUM
$189M
AUM Growth
+$16.4M
(+9.5%)
Cap. Flow
+$5.73M
Cap. Flow
% of AUM
3.03%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
313
New
30
Increased
179
Reduced
38
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
International Flavors & Fragrances
IFF
|
+$965K |
| 2 |
SRCL
Stericycle Inc
SRCL
|
+$936K |
| 3 |
IHS
IHS INC CL-A COM STK
IHS
|
+$729K |
| 4 |
Public Storage
PSA
|
+$723K |
| 5 |
Walmart Inc
WMT
|
+$709K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GTU
CENTRAL GOLD TR (CANADA)
GTU
|
+$1.35M |
| 2 |
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
|
+$1.2M |
| 3 |
CF Industries
CF
|
+$1.06M |
| 4 |
SM Energy
SM
|
+$963K |
| 5 |
National Health Investors
NHI
|
+$912K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.09% |
| 2 | Healthcare | 15.65% |
| 3 | Industrials | 15.23% |
| 4 | Consumer Discretionary | 13.29% |
| 5 | Consumer Staples | 9.95% |
Similar funds
LMC
RCG
PCM
WMN
FFS
PCI
KIA
PCM
Azzad Asset Management's Q4 2014 Portfolio in Review
As of Q4 2014, Azzad Asset Management held 313 positions worth $189M, up 9.5% from $173M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Azzad Asset Management deployed $5.73M of net new capital in Q4 2014, opening 30 new positions and adding to 179 existing holdings. Its largest new stake was Stericycle Inc: 7,436 shares worth $975K.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $375K trimmed.
- Azzad Asset Management's largest Q4 2014 buy was Stericycle Inc: 7,436 shares worth $975K.
- Azzad Asset Management added most to International Flavors & Fragrances in Q4 2014, an estimated $965K increase.
- Azzad Asset Management's biggest Q4 2014 reduction was Regeneron Pharmaceuticals, cutting an estimated $375K.
- Azzad Asset Management fully exited CENTRAL GOLD TR (CANADA) in Q4 2014, selling an estimated $1.35M.
- Azzad Asset Management's ten largest holdings make up 13% of its $189M portfolio in Q4 2014.
- Azzad Asset Management opened 30 new positions and closed 38 in Q4 2014.
- Azzad Asset Management's portfolio value rose 9.5% quarter-over-quarter to $189M.
Based on Azzad Asset Management's 13F filing for Q4 2014, filed 3 Apr 2024.